“I like the comprehensive and digestible style. Not just the good stuff, but the bad and the ugly too. And in a quick-to-read format. Nice to have in my inbox!”

“The TLDR newsletter pulls me in with the humor and keeps my attention with its on-point industry news summaries. Thanks to the TLDR team for saving me time every day.”

“As a business developer in the drug discovery and preclinical field, staying updated is crucial. I highly recommend this biotech newsletter—it offers a well-curated selection of important developments, written in an engaging and fun way. It's the perfect way to break up my day while keeping me informed on the latest in the industry.”

“What I appreciate about [the TLDR Biotech] newsletter is how easy to read it is. I really like that you don't write more than necessary about any of the news but rather provide links for further info. This way I definitely read it entirely and not stop halfway through.”

“I recommend TLDR Biotech to just about everyone - our founders, our co-investors, and even grad students who want to keep up with the must-know biotech news. It's one of the few newsletters I'm excited to open - it's got all the news I need to know, and in an easy-to-read format.”

“TLDR Biotech packs tons of useful information (good, bad, and ugly) into each daily newsletter. It's an easy, quick way to stay up to date on industry news, with links to more when you want to take a deep dive. I recommend it for staying on top of a rapidly changing industry as well as for business development fuel.”

“I’ve really enjoyed [the TLDR Biotech] updates - both the information they convey and how it’s conveyed. We do a lot of work in the CGT space and I like having [these] updates as a reminder for me to keep active in reading up on information.”

“TLDR Biotech has been an incredibly valuable resource to keep a pulse on the industry and get early notifications of important market signals. The presentation is clear, concise, and easy to consume, with a sprinkling of humor to keep it light. I read every update and learn something new from each one.”

“The TLDR Biotech newsletter is hands down my favorite biotech newsletter. The unique structure, which breaks down stories into The Good, The Bad, and The Ugly, really makes it stand out. What I appreciate most is the formatting of the news. It not only reports what's happening but also includes valuable context like the type of API, indication, dosing, therapeutic area, and other relevant details. It's the only newsletter I make a point to read every day!”

“TLDR Biotech has relentlessly delivered an incredible skim of biotech industry news, mergers, acquisitions, and regulatory updates for a full calendar year. I recommend this (free) newsletter, full of irreverent headlines, links to relevant announcements, and the occasional dad-joke meme, to young and old colleagues alike, and it's become a ritualistic part of my working mornings. The content is of highest quality, and the format is digestible and entertaining to read.

If you only subscribe to one biotech email newsletter, and need to stay on top of biotech and pharma news in all its formats - small molecule to biologics, stem cells to CAR-T, start ups to commercial launches - let TLDR Biotech be the one.”

“This is the first news letter I read almost daily and I personally find it super useful.”

“TLDR has become my go-to for easily accessible and organised BioPharma news. I love the way that all headlines are organised by category and is presented in an easy to read, informative and fun way.”

“A great newsletter for Business Development. Organized for Action!”

“I love the formatting, the GIFs are always spot on, and it's really easy to skim/read.”

“I go through cycles of newsletter subscriptions/cancellations. Right now I'm really appreciating TLDR Biotech:

Digestible summaries with links out to full reporting.

Covered from a clinical development + M&A perspective

More personality than the standard industry update

Free”

“TLDR Biotech is my one-stop-shop for biotech industry news. This daily newsletter presents the most important stories of the day it in a cleaver, easy to understand way.”

“TLDR Biotech is hugely valuable, and its the best thing I've found to keep me up to date in a quickly readable format.”